Proceedings of the Tenth Annual UT-ORNL-KBRIN Bioinformatics Summit 2011

The University of Tennessee (UT), the Oak Ridge National Laboratory (ORNL), and the Kentucky Biomedical Research Infrastructure Network (KBRIN), have collaborated over the past decade to share research and educational expertise in bioinformatics. One result of this collaboration is the joint sponsorship of an annual regional summit to bring together researchers, educators and students who are interested in bioinformatics from a variety of research and educational institutions. This summit provides unique opportunities for collaboration and forging links between members of the various institutions. This year, the Tenth Annual UT-ORNL-KBRIN Bioinformatics Summit was held at the University of Memphis in Memphis, Tennessee from April 1-3, 2011. A total of 225 participants pre-registered for the summit, with 146 from various Tennessee institutions and 60 from various Kentucky institutions. A number of additional participants came from universities and research institutions from other states and countries, e. g. University of Arkansas Medical Sciences, University of British Columbia, University of Cincinnati, Iowa State University, etc. Seventy-four registrants were faculty, with an additional 73 students, 50 staff, and 28 postdoctoral participants. The conference program consisted of three days of presentations. The first day included a pre-summit of talks by researchers supported by the Kentucky Biomedical Research Infrastructure Network (KBRIN), and three workshops covering the topics Next-Generation Sequencing, the workflow platform Galaxy, and GeneMANIA. The next two days were dedicated to scientific presentations divided into three plenary sessions on Pediatric Genetics, Pharmacogenomics and Systems Biology. Each session also included short talks selected from the submitted poster abstracts.

[1]  D. Roden,et al.  The Emerging Role of Electronic Medical Records in Pharmacogenomics , 2011, Clinical pharmacology and therapeutics.

[2]  Anton Nekrutenko,et al.  Galaxy CloudMan: delivering cloud compute clusters , 2010, BMC Bioinformatics.

[3]  E. D. Hyman A new method of sequencing DNA. , 1988, Analytical biochemistry.

[4]  A. Nekrutenko,et al.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences , 2010, Genome Biology.

[5]  S. Turner,et al.  Real-time DNA sequencing from single polymerase molecules. , 2010, Methods in enzymology.

[6]  C Polychronakos,et al.  Remapping the type I diabetes association of the CTLA4 locus , 2009, Genes and Immunity.

[7]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[8]  Mark E. J. Newman,et al.  Structure and Dynamics of Networks , 2009 .

[9]  Alan Aldrich,et al.  Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC) , 2010, Clinical trials.

[10]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[11]  Constantin Polychronakos,et al.  Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. , 2010, Human molecular genetics.

[12]  Hakon Hakonarson,et al.  Genome-wide association studies in type 1 diabetes , 2009, Current diabetes reports.

[13]  Joseph T. Glessner,et al.  A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene , 2007, Nature.

[14]  Sharon J. Diskin,et al.  Copy number variation at 1q21.1 associated with neuroblastoma , 2009, Nature.

[15]  John A. Sweeney,et al.  Genome-Wide Analyses of Exonic Copy Number Variants in a Family-Based Study Point to Novel Autism Susceptibility Genes , 2009, PLoS genetics.

[16]  Constantin Polychronakos,et al.  Association Analysis of Type 2 Diabetes Loci in Type 1 Diabetes , 2008, Diabetes.

[17]  Hakon Hakonarson,et al.  Genome-wide association studies in type 1 diabetes, inflammatory bowel disease and other immune-mediated disorders. , 2009, Seminars in immunology.

[18]  Ursula Amstutz,et al.  Pharmacogenomics of Cardiovascular Drugs and Adverse Effects in Pediatrics , 2011, Journal of cardiovascular pharmacology.

[19]  P. Shannon,et al.  Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing , 2010, Science.

[20]  T. Shaikh,et al.  Rare structural variation of synapse and neurotransmission genes in autism , 2011, Molecular Psychiatry.

[21]  Nazneen Rahman,et al.  Integrative genomics identifies LMO1 as a neuroblastoma oncogene , 2011, Nature.

[22]  Joseph T. Glessner,et al.  Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci , 2011, PLoS genetics.

[23]  Constantin Polychronakos,et al.  A Novel Susceptibility Locus for Type 1 Diabetes on Chr12q13 Identified by a Genome-Wide Association Study , 2008, Diabetes.

[24]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[25]  M. Loh,et al.  Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia , 2011, Nature Genetics.

[26]  D. Clayton,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[27]  Gideon Koren,et al.  The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology. , 2010, Thyroid : official journal of the American Thyroid Association.

[28]  Hua Xu,et al.  Data from clinical notes: a perspective on the tension between structure and flexible documentation , 2011, J. Am. Medical Informatics Assoc..

[29]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B Carleton,et al.  Economic impact of a genetic test for cisplatin-induced ototoxicity , 2012, The Pharmacogenomics Journal.

[31]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[32]  Gary D. Bader,et al.  GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop , 2010, Bioinform..

[33]  David Warde-Farley,et al.  GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function , 2008, Genome Biology.

[34]  BMC Bioinformatics , 2005 .

[35]  C Polychronakos,et al.  Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies , 2009, Journal of Medical Genetics.

[36]  Li-San Wang,et al.  Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia , 2010, BMC Medical Genetics.

[37]  C Polychronakos,et al.  The type I diabetes association of the IL2RA locus , 2009, Genes and Immunity.

[38]  Daniel J. Blankenberg,et al.  Galaxy: A Web‐Based Genome Analysis Tool for Experimentalists , 2010, Current protocols in molecular biology.

[39]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[40]  Joseph T. Glessner,et al.  Follow-Up Analysis of Genome-Wide Association Data Identifies Novel Loci for Type 1 Diabetes , 2009, Diabetes.

[41]  Quaid Morris,et al.  Fast integration of heterogeneous data sources for predicting gene function with limited annotation , 2010, Bioinform..

[42]  Joseph T. Glessner,et al.  From Disease Association to Risk Assessment: An Optimistic View from Genome-Wide Association Studies on Type 1 Diabetes , 2009, PLoS genetics.

[43]  Hakon Hakonarson,et al.  A genome-wide study reveals copy number variants exclusive to childhood obesity cases. , 2010, American journal of human genetics.

[44]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[45]  R. Nutter,et al.  Applied Biosystems SOLiD™ System: Ligation‐Based Sequencing , 2008 .

[46]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[47]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.